Latest News
Day 2 from Euretina 2026
Explore the highlights from Day 2 of the Euretina Congress 2026 in Vienna, capturing sessions, speakers, delegates and memorable moments from across the day.
Navigating the Frontier of IRDs: Expert Perspectives on Luxturna Outcomes, Genotype Stratification, and AI-Driven Trial Endpoints
Session on inherited retinal diseases and paediatrics featured talks addressing unmet needs, updates on outcomes of patients treated with voretigene neparvovec gene therapy, and new insights about select genetic diseases.
Unraveling PVR: From Molecular Biomarkers to Advanced Surgical and Medical Rescue
Proliferative vitreoretinopathy (PVR) was the focus of the Friday Euretina session on vitreoretinal surgery.
Frontiers in Retinal Innovation: Late-Breaking Trial Results Highlight Gene Therapies, Subretinal Implants, and Extended Delivery in nAMD and GA
Nine speakers present results from preclinical and in-human clinical trials of interventions designed for patients with genetic diseases, neovascular age-related macular degeneration (nAMD), and geographic atrophy (GA).
High Stakes and Surgical Drama: EuroVeRsion 2026 Finalists Showcase Remarkable Rescues in Room 4
The EuroVersion International Surgical video case contest takes place on Friday, 2 October 2026 from 12:15 – 13:15 CEST in Room 4.
From Connection to Career Impact: Prof. Anat Loewenstein on Five Years of the EURETINA Women in Retina Initiative
Join the Women in Retina networking breakfast being held Saturday, October 3, 2026, from 07:30 – 09:00 CEST (no pre-registration required), Location: World Retina Plaza.
Meet the Winners: Best Free Papers, ePosters and Videos
The winners of this year’s Best Free Paper, Best ePoster and Best Video awards were announced during the Opening Ceremony. Here is where and when to see each winning presentation.
The European Board of Ophthalmology and EURETINA Celebrate 4 years of FEBOS-R Subspecialty Certification by Awarding FEBOS-R (Hons) Diplomas
8 Exam Leaders join Prof Nicole Eter and Prof Jens Folke Kiilgaard as FEBOS-R (Hon) Awardees
Elevating Science: Explore the Revamped Free Paper Forums and Poster Hub
At the beginning of her keynote address on Artificial Intelligence (AI) in Medicines Development: Perspective From an EU Medicines Regulator, Jane Moseley, Senior Scientific Officer at the European Medicines Agency (EMA) said she would be addressing three key questions: Where do we want to get to with AI in medicines development?; Where are we now?; and How are we going to get there?
Kreissig Lecture Preview: Optimising Tamponades to Repair Rhegmatogenous Retinal Detachment
Kreissig Award lecturer reviews the evidence base and scientific rationale for use of vitreous cavity tamponades in the repair of rhegmatogenous retinal detachment and looks ahead to the possibility of a tamponade-free future.
Gisbert Lecture Preview: Understanding Diabetic Tractional Retinal Detachment and Generating Evidence to Improve Patient’s Care
Gisbert Richard Lecturer will review existing evidence regarding the development and management of diabetic tractional retinal detachment and research needed to fill knowledge gaps that will enable better patient care.